FDA Circular No. 2010-003
REVISED FEES FOR SEMINAR ON LICENSING OF DRUG ESTABLISHMENTS
(NAR) VOL. 21 NO.1/ JANUARY - MARCH 2010
[ FDA CIRCULAR NO. 2010-003, January 20, 2010 ]
REVISED FEES FOR SEMINAR ON LICENSING OF DRUG ESTABLISHMENTS
Pursuant to the provisions of R.A. 9711 (Food and Drug Administration Act) and Administrative Order No. 56, s. 1989 dated January 1989, a series of seminars on Licensing of Drug Establishments had been scheduled for CY 2010. Accordingly, revised fees have been implemented to accommodate the overhead expenses of Food and Drug Administration, to wit: ESTABLISHMENT SEMINAR FEE Manufacturers and Traders(Drug, Cosmetic P1,2000.00 (whole day) & Medical Device) This circular takes effect immediately and until sooner revoked. Adopted: 20 Jan. 2010
(SGD.) NAZARITA T. TACANDONG, RPh., MPA Acting Director IV